A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-017)
PHASE1CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
October 2, 2023
Primary Completion Date
December 20, 2023
Study Completion Date
February 16, 2024
Conditions
Healthy
Interventions
DRUG
Nemtabrutinib
Oral Tablet
Trial Locations (1)
96813
Labcorp Clinical Research Unit Inc. (Site 0001), Honolulu
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT06772818 - A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-017) | Biotech Hunter | Biotech Hunter